Results 141 to 150 of about 3,497,460 (348)
What personal stories do people with a chronic skin disease have to tell? This was Tanny Dobbelaar's main question in 2001 when she initiated the project “Heftig Vel’’, which may be translated from Dutch as “Severe Skin”. In this essay Dobbelaar shows a selection of what she and photographer Adrienne Norman tried to communicate at that time through a ...
openaire +4 more sources
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim+18 more
wiley +1 more source
Allyson L. Byrd, Y. Belkaid, J. Segre
semanticscholar +1 more source
Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry+16 more
wiley +1 more source
Skin effect in rectangular conductors at high frequencies
John Cockcroft
openalex +1 more source
Some Historical and Clinical Remarks on the Effect of Light on the Skin and Skin Diseases [PDF]
C. Rasch
openalex +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla+13 more
wiley +1 more source
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999‐2021. RA‐ILD patients were
Bryant R. England+9 more
wiley +1 more source